Searched for
FDA DRUG APPLICATIONS
Anthropic's Claude cut Enveda's drug records' review time by 89%Colorado-based biotechnology company Enveda developed a CMC Document Processor to help reviewers identify errors, inconsistencies and poten...- Stocks in news: Infosys, Kotak Mahindra Bank, YES Bank, Raymond, BPCL, Coforge and Senco GoldIndian equity markets have faced a decline for four consecutive sessions, with the Nifty falling significantly. Various factors, including ...
- Maharashtra FDA bans sale of loose spice powders, mixed spices to curb adulterationMaharashtra's FDA has implemented a ban on the sale of loose and unpacked spice powders. This initiative aims to prevent adulteration and e...
- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- Maharashtra FDA cancels Cipla's Pune warehouse licences over Reactin Plus packaging claimsMaharashtra's Food and Drug Administration has cancelled Cipla Pharma's distribution licenses due to serious violations. The FDA discovered...
- Fortis, Apollo, other hospital stocks slump up to 10% in 2 days after SC questions steep markups. Buying opportunity?Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...
- Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target priceJefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...
- Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...
- Why is Summit Therapeutics share price up today by 22%?Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...
- In healthcare, the patient is the least informed consumerSignificant price differences in healthcare consumables have drawn attention, prompting calls for better consumer protection. Maharashtra's...
- Vitruvias Therapeutics thyroid tablet recall: FDA issues serious Class I warning over ‘superpotent’ medicine — check lot number, expiration date and what patients should knowVitruvias Therapeutics thyroid tablet recall: The FDA has issued a serious Class I recall for one lot of Vitruvias Therapeutics thyroid tab...
- US FDA plans move to speed up vape, pouch approvals: ReportThe FDA is preparing to unveil new measures to accelerate approvals for vaping products and nicotine pouches. Changes will likely include r...
- Celldex shares slip 15% as safety concerns cloud skin drug trial win(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...
- Biomoneta launches Avata Air through Panasonic’s MirAIe Lifestyle platformBiomoneta’s microbial air-decontamination technology has previously been deployed and evaluated in healthcare environments, including inten...
- Banned beauty products are still one click away in India and around the worldBanned skin-bleaching products containing mercury are still available for purchase online. These illegal items are found on Amazon, Temu, a...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- Vimal Elaichi case: Delhi HC rejects makers' plea against FDA notices to Shah Rukh Khan, Ajay Devgn & Tiger ShroffThe Delhi High Court has ruled against the Vimal Elaichi makers, dismissing their plea regarding Maharashtra FDA notices aimed at celebriti...
- Delhi HC to pass order on Monday on Vimal Elaichi makers' plea seeking to quash show-cause notices against actorsThe Delhi High Court will soon decide on its jurisdiction to hear a plea. This plea challenges show-cause notices issued to Vimal Elaichi b...
- Mumbai ISKCON Govinda's Restaurant licence suspended after FDA finds pest infestation, raw materials not cleaned before cookingMumbai’s FDA has suspended the licence of ISKCON’s Govinda’s Restaurant after an inspection found pest infestation, uncleaned raw materials...
Load More
